Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |